Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-K, filed February 24, 2026.
- Filed
- Feb 24, 2026, 8:16 AM EST
- Fiscal year
- FY2026
- Accession
- 0001104659-26-018859
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|---|
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||
| Purchase of investment securities | (86,151) | (105,289) | (127,469) |
| Proceeds from maturities and sales of investment securities | 81,062 | 98,527 | 118,309 |
| Purchase of property and equipment | (310) | (1,153) | (312) |
| Acquisition of Zynerba Pharmaceuticals, Inc., net of cash acquired | — | — | (36,967) |
| Acquisition of Epygenix Therapeutics, Inc., net of cash acquired | — | (33,069) | — |
| Payment of milestones | (19,250) | (1,000) | — |
| Payment of upfront fee related to license agreements (1) | (15,000) | (25,500) | — |
Item 8. Financial Statements and Supplementary Data.
FAQ
- What is Harmony Biosciences Holdings, Inc.'s capex?
- Harmony Biosciences Holdings, Inc. (HRMY) reported capex of $107K in Q4 2025.
- How has Harmony Biosciences Holdings, Inc.'s capex changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s capex decreased by 79.1% year-over-year, from $513K to $107K.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s capex?
- Over 3 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s capex has grown at a 1.3% compound annual growth rate (CAGR), from $298K to $310K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Harmony Biosciences Holdings, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude